These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 22388754

  • 21. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G.
    Blood; 1996 Sep 01; 88(5):1765-70. PubMed ID: 8781433
    [Abstract] [Full Text] [Related]

  • 22. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L, Zain J, Rosen ST, Querfeld C.
    Cancer Treat Res; 2019 Sep 01; 176():249-268. PubMed ID: 30596222
    [Abstract] [Full Text] [Related]

  • 23. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.
    Onaindia A, Montes-Moreno S, Rodríguez-Pinilla SM, Batlle A, González de Villambrosía S, Rodríguez AM, Alegre V, Bermúdez GM, González-Vela C, Piris MA.
    Histopathology; 2015 May 01; 66(6):846-55. PubMed ID: 25131361
    [Abstract] [Full Text] [Related]

  • 24. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK, Eagle RC, Wojno TH, Neufeld KR, Grossniklaus HE.
    Ophthalmology; 2010 Feb 01; 117(2):343-51. PubMed ID: 19969358
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF, Jansen PM, Meijer CJ, Willemze R.
    Br J Dermatol; 2009 Jul 01; 161(1):121-7. PubMed ID: 19416236
    [Abstract] [Full Text] [Related]

  • 26. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
    Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES.
    Am J Surg Pathol; 2012 May 01; 36(5):716-25. PubMed ID: 22367293
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Linfoma anaplásico de células T grandes primario cutáneo CD30+. Serie de nueve casos.
    Ruiz-Arriaga LF, Landgrave-Gómez I, Toussaint-Caire S, Lacy-Niebla RM, Vega-Memije ME.
    Gac Med Mex; 2019 May 01; 155(2):130-135. PubMed ID: 31056597
    [Abstract] [Full Text] [Related]

  • 32. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
    Bisig B, Cairoli A, Gaide O, Somja J, Bregnard C, Gaulard P, Xerri L, Lefort K, Missiaglia E, Gilliet M, Hohl D, Guenova E, de Leval L.
    Virchows Arch; 2022 Oct 01; 481(4):653-657. PubMed ID: 35366115
    [Abstract] [Full Text] [Related]

  • 33. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE, Bayerl MG, Bruggeman RD, Mauger D, Ioffreda MD, Abou-Elella A, Helm KF.
    Am J Surg Pathol; 2005 Apr 01; 29(4):452-9. PubMed ID: 15767797
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA.
    Virchows Arch; 2021 Aug 01; 479(2):377-383. PubMed ID: 33604757
    [Abstract] [Full Text] [Related]

  • 36. Primary "cutaneous" T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review.
    Salama S.
    Am J Dermatopathol; 2005 Jun 01; 27(3):217-23. PubMed ID: 15900125
    [Abstract] [Full Text] [Related]

  • 37. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.
    Br J Dermatol; 2008 Jun 01; 158(6):1280-7. PubMed ID: 18410414
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.
    Prieto-Torres L, Rodriguez-Pinilla SM, Onaindia A, Ara M, Requena L, Piris MÁ.
    Haematologica; 2019 Feb 01; 104(2):226-235. PubMed ID: 30630983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.